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Abstract We can be motivated when reward depends on performance, or merely by the
prospect of a guaranteed reward. Performance-dependent (contingent) reward is instrumental,
relying on an internal action-outcome model, whereas motivation by guaranteed reward may
minimise opportunity cost in reward-rich environments. Competing theories propose that each
type of motivation should be dependent on dopaminergic activity. We contrasted these two types
of motivation with a rewarded saccade task, in patients with Parkinson’s disease (PD). When PD
patients were ON dopamine, they had greater response vigour (peak saccadic velocity residuals)
for contingent rewards, whereas when PD patients were OFF medication, they had greater vigour
for guaranteed rewards. These results support the view that reward expectation and contingency
drive distinct motivational processes, and can be dissociated by manipulating dopaminergic
activity. We posit that dopamine promotes goal-directed motivation, but dampens reward-driven
vigour, contradictory to the prediction that increased tonic dopamine amplifies reward expectation.
Introduction
Organisms expend more effort when their actions can lead to rewards, as the value of the reward
offsets the extra effort expended to attain them (Kool and Botvinick, 2018; Manohar et al., 2015;
Niv et al., 2006; Shenhav et al., 2017). They will even do so if the extra effort does not increase the
reward they receive (Glaser et al., 2016; Milstein and Dorris, 2007; Xu-Wilson et al., 2009), indi-
cating that mere expectation of reward is enough to justify the effort cost. Motivation, which pro-
motes this effort expenditure, has two facets: it allows actions to be directed towards goals, and it
energises our actions when rewards are expected (Niv et al., 2006). These two aspects are not
always coupled. For example, employees might be salaried, where a fixed reward is guaranteed irre-
spective of achievements, or they might receive merit-based pay that is contingent on meeting per-
formance targets (Lazear, 2000).
Contingent rewards motivate us because we understand the causal relation between successful
actions and reward. This is instrumental, in that we apply knowledge of action-outcome associations.
For instance, people must realise that merit-based pay depends on their performance for it to incen-
tivise them. In animals, dopaminergic input to dorsal striatum is necessary for instrumental motiva-
tion (Lex and Hauber, 2010b).
In contrast, reward that is independent of what an agent does might motivate us because in a var-
iable environment, we capitalise on rewards while they are available (Niv et al., 2007). One pro-
posed mechanism for this is that tonic dopamine encodes expected reward rate, such that in a rich
environment agents are motivated to respond faster to maximise the rewards they receive
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(Niv et al., 2007). Equally, dopamine can be viewed as signalling an opportunity cost– time is more
costly when reward is available, and so organisms act faster (Otto and Daw, 2019; Shadmehr et al.,
2010). The dopaminergic drive has not only generalised motivating effects, termed vigour
(Beierholm et al., 2013; Guitart-Masip et al., 2011; Niv et al., 2007), but also context-specific
effects. For example, a stimulus that predicts rewards drives conditioned responses that are
uncoupled with reward (Lovibond, 1981) – similar to how salary increases might improve job perfor-
mance. This phenomenon, known as Pavlovian-to-Instrumental transfer, requires dopamine projec-
tions to nucleus accumbens (Hall et al., 2001; Kelley and Delfs, 1991; Talmi et al., 2008;
Wassum et al., 2013; Wyvell and Berridge, 2000). Similarly, animals tend to approach stimuli asso-
ciated with rewards, even in the absence of action-contingency, a behaviour called autoshaping or
sign-tracking, which also relies on nucleus accumbens dopamine (Day et al., 2006; Di Ciano et al.,
2001).
The dopaminergic basis of instrumental and Pavlovian motivation could potentially explain the
impaired motivation seen in PD patients and the rescue of such deficits by rewards (Ang et al.,
2018; Chong et al., 2015; de Wit et al., 2011; Kojovic et al., 2014). However in certain situations,
motivation by reward can paradoxically be stronger in patients with low dopamine (Aarts et al.,
2012; Timmer et al., 2018), making dopamine’s exact role in motivation unclear.
These two effects of contingent and expected rewards frequently overlap in real life and in previ-
ous experiments – higher stakes raise reward expectation, but also mean that actions carry more
weight. However, experimental control of expectation and contingency allows them to be dissoci-
ated (Manohar et al., 2017), which reveals that both contingency and expectation can separately
motivate behaviour, and that these effects are independent rather than correlated or antagonistic,
suggesting distinct mechanisms.
We used this incentivised saccade task (Manohar et al., 2017) here to test PD patients ON and
OFF their dopaminergic medication, along with healthy age-matched controls. We tested the two
predictions that dopamine is involved in motivation by expected rewards, and by contingent
rewards.
Results
Dopamine promotes contingent motivation and attenuates reward-
expectation motivation
Participants made saccades to a target after hearing cues indicating how reward would be deter-
mined (Figure 1b). To measure motivation by contingent rewards, we compared trials where
rewards were delivered depending on participants’ response times (Performance), to trials where
rewards were given with 50% probability (Random). We matched the average reward rate so that
both these conditions had identical reward expectation and uncertainty, and only differed in their
contingency. To measure motivation by reward expectation, we compared trials with a guaranteed
reward (10 p) to those with a guaranteed no-reward (0 p). In both these conditions rewards were
delivered unconditionally, and only differed in terms of expected reward. We tested 26 PD patients
ON and OFF dopaminergic medication (PD ON and PD OFF) and 29 healthy age-matched controls
(HC) on a rewarded eye-movement task that separated effects of contingent and non-contingent
motivation (see Figure 1a for task, see Table 1 for participant details).In all trials, feedback was
given about whether the response was fast or slow, in addition to the reward received, to control for
intrinsic motivation. A saccade’s velocity is tightly governed by its amplitude, a relation known as the
‘main sequence’ (Bahill et al., 1975). To account for this, we regressed out the effect of amplitude
on peak velocity leaving peak saccade velocity residuals as our main measure of response vigour
(see Figure 1e), as in previous work (Blundell et al., 2018; Manohar et al., 2017;
Muhammed et al., 2020; Muhammed et al., 2016; Van Opstal et al., 1990). This measures how
much faster each saccade is than the speed predicted from its amplitude. Thus, positive (negative)
residuals mean a particular saccade was faster (slower) than predicted by the main sequence, and
makes response vigour independent of any changes to saccade amplitude also caused by our manip-
ulations or by group differences between PD patients and HC. We did this regression for each par-
ticipant and session separately, but across conditions. A three-way repeated-measures ANOVA
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Figure 1. Saccade task design and example eye-tracking traces. (a) Trial design: participants fixated on the centre, heard a cue for the condition
(Performance/Random/10 p/0 p), waited a delay (1400/1500/1600 ms) and then looked towards to the circle that lit up, and were given 10 p or 0 p
reward depending on the condition, along with feedback on their response time (fast/slow). (b) To measure contingent motivation, we compared
‘Performance’ trials, where participants had to be faster than their median RT to win reward (thus giving 50% trials rewarded on average), with ‘Random’
trials where a random 50% of trials were rewarded. To measure motivation by expected reward we compared ‘10 p’ trials where rewards were
guaranteed, with ‘0 p’ trials where no-reward was guaranteed. (c) Example eye-position traces for one participant and condition (different colours are
different trials). (d) Example mean velocity and acceleration profiles for all PD ON in the 10 p condition. (e) Example of the main sequence and velocity
residuals – the points show a subset of individual trials illustrating the ‘main sequence’ relationship where larger saccades have greater velocity, shown
Figure 1 continued on next page
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tested whether dopamine differentially affected contingent and guaranteed motivation – manifest
by a three-way (contingency*motivation*drug) interaction.
Dopaminergic medication significantly modulated how contingent and guaranteed motivation
affected motor vigour (Figure 2a, three-way interaction on peak velocity residuals, p=0.0023; see
Table 2 for statistics). This was because, when ON medication, patients were motivated by contin-
gency but not reward expectation (separate two-way ANOVA in PD ON: contingency*motivation,
p=0.0170; see Supplementary file 1A), whereas after overnight withdrawal of medication there was
a borderline significant interaction in the opposite direction, as PD OFF were motivated by reward
expectation but not contingency (PD OFF ANOVA: p=0.0501; Supplementary file 1A). This indi-
cates that when PD patients were ON medication, motivation was strongest when reward was con-
tingent on performance, but when they were OFF medication, patients were motivated by
guaranteed rewards.
To confirm that the effects on peak velocity residuals were not driven by changes in other aspects
of saccades, the same 3-way ANOVA was run on each of the other saccade measures. There were
no significant effects on saccadic amplitude (see Table 2 and Figure 2c). Saccadic RT had an effect
of contingency as saccades started faster for Performance and Random conditions than 10 p or 0 p
conditions (Figure 2d, p=0.0396). Endpoint variability had a contingency*motivation interaction
(Figure 2e, p=0.0482) as variability was higher for 0 p condition. Raw peak velocity had an effect of
motivation, as both types of motivation increased speed (Figure 2f, p=0.0110), although this will
include effects of changes in amplitude (via the main sequence) which showed a borderline signifi-
cant effect of motivation (Figure 2c, p=0.0607).
Figure 1 continued
by the regression line. The distance from each point to its line is the velocity residual, which we take as out main measure of response vigour. (f) Peak
velocity of individual saccades increases with the amplitude of movement – the ‘main sequence’; example showing the 10 p condition, for PD ON, OFF
and HC. Saccadic vigour, our measure of interest, was indexed by the residuals after regressing out amplitude from peak velocity, for each participant.
Table 1. Participant demographics for PD patients and Healthy Controls (HC) included in the
analysis.
Standard deviations are given in parentheses. **=p < 0.01 (independent samples t-test).
ACE = Addenbrooke’s Cognitive Exam, AMI = Apathy and Motivation Index, HADS = Hospital Anxi-
ety and Depression scores (A and D given separately), BDI-II = Beck Depression Inventory-II,
FSS = Fatigue Severity Scale, UPDRS-III = Unified Parkinson’s disease rating scale Part 3, performed
ON and OFF medication, LED = Daily Levodopa Equivalent Dose, # on agonists = number of patients
taking dopamine agonists in addition to levodopa.
PD HC
Number 26 29
Age 67.69 (1.48) 67.41 (6.83)
Gender (M:F) 19:7 15:14
ACE 93.04 (6.47) 97.10 (2.11)**
AMI 1.48 (0.56) 1.28 (0.47)
HADS-A 2.92 (2.92) 4.29 (2.79)
HADS-D 2.50 (1.84) 2.17 (1.83)
BDI-II 4.90 (3.60) 5.84 (3.78)
FSS 3.19 (1.21) 3.02 (1.03)
UPDRS-III ON 26.69 (9.20) N/A
UPDRS-III OFF 35.04 (11.17) N/A
LED 490.23 (324.28) N/A
# on agonists 6 N/A
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Figure 2. Differential effects of dopamine on two types of motivation. The mean measures for the four conditions (Performance, Random, Guaranteed
10p, Guaranteed 0p) for each variable, with individual data points. The difference between Performance and Random shows the effect of Contingent
motivation, while the difference between 10p and 0p shows the motivating effect of reward expectation. (a) Peak velocity residuals indexed behavioural
vigour. When ON dopamine, patients were motivated to invigorate their saccades when reward depended on response time, but not when expecting a
Figure 2 continued on next page
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The HC peak velocity residuals were not affected by contingency, motivation or the interaction
(p>0.05; see Table 3), suggesting that healthy older adults do not adjust their response vigour for
contingent or guaranteed rewards. There were also no significant effects on amplitude, saccadic RT,
or raw peak velocity in HC, although endpoint variability did have a significant contingency*motiva-
tion interaction (p=0.0048; see Table 3). Post-hoc pairwise comparisons showed this was due to
guaranteed rewards significantly reducing variability (p=0.0316), while contingent rewards did not
(p=0.1219).
We also compared both PD ON and OFF separately against the HC with three-way mixed
ANOVA, to see under which conditions patients deviated from healthy behaviour. As expected, HC
had overall larger amplitudes, quicker saccadic RTs and lower endpoint variability than both PD ON
or OFF (Figure 2, see Supplementary file 1B-C for statistics). The use of peak velocity residuals
rather than raw velocity factors out the effects of PD on movement amplitude, allowing comparison
of the motivational changes in velocity while controlling for differences in the main sequence
(Bahill et al., 1975; Manohar et al., 2017). HC did not significantly differ from PD ON or OFF in
peak velocity residuals, although their pattern was numerically closest to PD ON with greater contin-
gent motivation.
We additionally checked whether there were practice effects in the PD patients, in case patients
behaved differently on their second session due to different expectations. We found no effects or
interactions of session on any measure in PD patients (p>0.05).
Velocity profiles
The effects above demonstrate peak velocity shows strong effects of reward and dopamine, so next
we examined the time-course of how velocity was modulated during a saccade. We computed the
velocity across time within the movements, and compared the reward effects for PD ON and OFF
using cluster-wise permutation tests. Contingent rewards (Performance – Random) did not signifi-
cantly affect velocity or acceleration for PD ON or OFF, as permutation tests for each condition and
the difference between conditions found no significant clusters (cluster-wise permutation tests:
p>0.05; Figure 3a&b). However, guaranteed rewards (10 p – 0 p) lead to greater velocity early in
the saccade for PD OFF (p<0.05; Figure 3c), which was significantly different from PD ON (p<0.05).
Acceleration traces showed this was due to PD OFF having greater acceleration early in the move-
ment (Figure 3d, p<0.05). HC showed no effects of contingent or guaranteed rewards on velocity or
acceleration, perhaps unsurprising as there were no differences in overall velocity as reported above.
Permutation testing revealed no differences between HC and PD ON or OFF for velocity or accelera-
tion (p>0.05).
Faster movements are known to be more error-prone (Harris and Wolpert, 1998; Harris and
Wolpert, 2006), but motivation can attenuate this effect, making movements more accurate
(Manohar et al., 2019). Autocorrelation of eye position over time within saccades provides an indi-
cator of corrective motor signals during movements: noise accumulates during movements, so that
variability early in a movement causes endpoint error. This is manifest in autocorrelation, where
across trials the eye position at early time-points predicts late time-points. Negative feedback signals
correct movement errors during the saccade, and manifest as reductions in this autocorrelation
(Codol et al., 2020; Manohar et al., 2019). This feedback, provided by corrective motor signals,
can be increased by incentives (Codol et al., 2019; Manohar et al., 2019). In the current study,
guaranteed rewards led to greater autocorrelation early in the saccades for PD OFF than ON
(Figure 4e & g). This coincides with the greater acceleration PD OFF patients had at the beginning
Figure 2 continued
guaranteed reward. In contrast, when OFF dopamine, vigour was driven by expectation of guaranteed reward, but not by contingency (F (1, 200) =
9.5190, p = .0023, h2
p
= . 0454). (b) HC were similar to PD ON dopamine (please note the different y-axis limits). (c–e) No dopaminergic effects were
observed for (c) saccade amplitude, (d) saccade RT, (e) endpoint variability, or (f) raw peak velocity, although PD patients had slower, smaller and more
variable saccades than HC. All measures are in visual degrees, except saccade RT (ms). Error bars show within-subject SEM. Statistics are presented in
Table 2. Data are available in Figure 2—source data 1.
The online version of this article includes the following source data for figure 2:
Source data 1. Source individual data for all saccade measures for PD ON, OFF and HC.
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Table 2. Statistics for main behavioural analyses.
Three-way (motivation*contingency*drug) repeated-measures ANOVA on each behavioural measure,
for the PD patients ON and OFF medication. An effect of contingency means the guaranteed condi-
tions (10 p, 0 p) were different to the contingent conditions (Performance, Random). An effect of moti-
vation means the 10 p and Performance conditions were different to the Random and 0 p conditions.
An interaction of the two means that contingent rewards differed from guaranteed rewards. The Con-
tingency * Motivation * Drug condition means that the effects of contingent and non-contingent
rewards differed by PD medication state. Significant effects are highlighted in red. *p < 0.05,
**p < 0.01.
Measure Effect F (1, 200) p h2
p
Peak Velocity Residuals Motivation 9.7704 *.0020 .0466
Contingency 0.0194 . 8895 . 0001
Drug 0.0004 . 9850 . 0000
Motivation * Contingency 0.0051 . 9429 . 0000
Motivation * Drug 0.2626 . 6089 . 0013
Contingency * Drug 11.1072 **.0010 . 0526
Contingency * Motivation * Drug 9.5190 **.0023 . 0454
Amplitude Motivation 3.5577 . 0607 . 0175
Contingency 1.2284 . 2690 . 0061
Drug 0.0000 . 9984 . 0000
Motivation * Contingency 0.5545 . 4573 . 0028
Motivation * Drug 0.2278 . 6337 . 0011
Contingency * Drug 1.7763 . 1841 . 0088
Contingency * Motivation * Drug 0.0287 . 8655 . 0001
Saccadic RT Motivation 3.4333 . 0654 . 0169
Contingency 4.2922 *.0396 . 0210
Drug 0.3560 . 5514 . 0018
Motivation * Contingency 0.3663 . 5457 . 0018
Motivation * Drug 0.0694 . 7925 . 0003
Contingency * Drug 0.6246 . 4303 . 0031
Contingency * Motivation * Drug 0.0185 . 8920 . 0001
Endpoint Variability Motivation 2.6780 . 1033 . 0132
Contingency 3.6181 . 0586 . 0178
Drug 1.0095 . 3162 . 0050
Motivation * Contingency 3.9524 *.0482 . 0194
Motivation * Drug 1.2787 . 2595 . 0064
Contingency * Drug 1.3819 . 2412 . 0069
Contingency * Motivation * Drug 0.1626 . 6872 . 0008
Raw Peak Velocity Motivation 6.5921 *.0110 .0319
Contingency 0.3831 .5366 .0019
Drug 1.8937 .1703 .0094
Motivation * Contingency 0.1179 .7316 .0006
Motivation * Drug 0.0563 .8126 .0003
Contingency * Drug 0.5462 .4608 .0027
Contingency * Motivation * Drug 2.4061 .1224 .0119
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of saccades to guaranteed rewards (Figure 3d), as faster movements have greater motor noise
(Harris and Wolpert, 1998; Harris and Wolpert, 2006). Notably, this reward-related autocorrela-
tion did not persist until the end of the saccade, suggesting that negative feedback corrected it.
However, as we did not find decreased autocorrelation around the end of the saccades, this repre-
sents only indirect evidence of negative feedback.
No correlation of the velocity effects for the distinct motivational
processes
Previous work had shown that motivation by contingent and guaranteed reward did not correlate
across participants (Manohar et al., 2017), so we asked whether dopamine’s effects upon these two
types of motivation was also uncorrelated. We found no correlation between effects of contingent
and guaranteed rewards on peak saccade velocity residuals in PD ON, PD OFF or HC separately,
nor a correlation between medication states, nor between the drug-induced changes in the effects
(p>0.05; see Figure 5 legend for statistics). This suggests that the two effects are separate and inde-
pendent, and not antagonistic within the same person. In particular, the degree to which dopamine
improved performance-contingent motivation did not predict the degree to which it reduced moti-
vation by guaranteed rewards.
Source data are available in Figure 5—source data 1.
Pupil dilatation
We examined pupil dilatation after the cue onset and before the target appeared (after 1400 ms).
Previous research has shown a greater effect of contingent than guaranteed reward on pupil dilata-
tion, maximal around 1200 ms after the cue (Manohar et al., 2017), so we used a window-of-interest
analysis on the mean pupil dilatation 1000–1400 ms after the cue. There were no significant effects
or interactions (p>0.05; Figure 6, see Supplementary file 2A-C for statistics), suggesting that dopa-
mine and reward did not affect pupil responses in PD patients.
We also used a hypothesis-free analysis, using cluster-wise permutation testing across the whole
time-course to look for significant differences between conditions and groups, which also found no
significant effects (p>0.05).
Table 3. Statistics for behavioural analysis on HC saccade data.
HC had a motivation*contingency interaction for endpoint variability, as only expected rewards
decreased variability. **=p < 0.01.
Group Effect F (df = 1, 112) p h2
p
Peak Velocity Residuals Motivation 0.9019 . 3443 . 0080
Contingency 0.3463 . 5574 . 0031
Motivation * Contingency 0.6995 . 4047 . 0062
Amplitude Motivation 2.3510 . 1280 . 0206
Contingency 0.0255 . 8734 . 0002
Motivation * Contingency 1.2551 . 2650 . 0111
Saccade RT Motivation 3.2227 . 0753 . 0280
Contingency 2.5743 . 1114 . 0225
Motivation * Contingency 2.7992 . 0971 . 0244
Endpoint Variability Motivation 0.9304 . 3368 . 0082
Contingency 0.6651 . 4165 . 0059
Motivation * Contingency 8.2781 **.0048 . 0688
Raw Peak Velocity Motivation 1.1321 .2896 .0100
Contingency 0.1615 .6885 .0014
Motivation * Contingency 0.2538 .6154 .0023
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We found no correlations between pupil dilatation and motivation effects in any group, or overall
(p>0.05; Figure 6—figure supplement 1). Thus, the vigour effects were not related to pupillary dila-
tation before the movement.
PD severity
We looked to see whether the dopaminergic effects on velocity residuals could be tied to PD symp-
tom expression. The UPDRS (Martı´nez-Martı´n et al., 2015) is a measure of PD symptom severity
and was performed in each session; part III measures motor symptom severity. We found no correla-
tions between UPDRS-III scores and reward effects on peak velocity residuals in PD ON (Guaranteed:
r =  0.1256, p=0.5410; Contingent: r =  0.2327, p=0.2527) or OFF (Guaranteed: r =  0.2067,
p=0.3110; Contingent: r = 0.1553, p=0.4487). Thus, the reward effects were unrelated to PD symp-
tom severity.
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Figure 3. Motivational effects on instantaneous velocity and acceleration within a saccade. The top row shows the effects of contingent rewards (i.e.
measures in Performance conditions minus the Random condition), and the bottom row shows effects of guaranteed rewards (10 p condition minus 0 p
condition). The x-axis is % of normalised time where 0 indicates the start of a saccade, and 100 is the end. The instantaneous velocity (a and c) is
increased by contingent (a) and guaranteed (c) rewards, and PD patients OFF have an earlier and greater increase in velocity for guaranteed rewards
than PD ON. The orange bar shows time-points where PD OFF had velocity significantly greater than zero (cluster-wise permutation tests, p<0.05), the
black bar shows time-points where PD ON and OFF significantly differed (PD ON and HC did not differ from zero, so there are no blue or yellow bars).
Acceleration traces (b and d) showed this was due to guaranteed motivation increasing acceleration at the start of the movement for PD OFF (d;
significant cluster, p<0.05). Shading shows SEM. Source data are available in Figure 3—source data 1. Figure 3—figure supplement 1. Individual
participants’ velocity and acceleration traces.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Source individual data for saccade velocity and acceleration for PD ON, OFF and HC.
Figure supplement 1. Individual participants’ velocity and acceleration traces.
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Depression and apathy
We gave participants questionnaires measuring apathy, the AMI (Ang et al., 2017) and depression,
BDI-II and HADS (Beck et al., 1996; Zigmond and Snaith, 1983). We found no significant correla-
tions between these questionnaires and contingent or guaranteed motivational effects on peak
velocity residuals in PD ON or OFF (p>0.05, see Supplementary file 4 for statistics).
Fixation period
We looked at whether motivation was affecting behaviour during the fixation period (1400 ms
between condition cue onset and target onset) differently, which could potentially lead to differen-
ces during the movements. We excluded trials with saccades, blinks, deviations greater than 1.8˚
and segments with velocities greater than 30˚s 1.
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Figure 4. Motivational effects on eye-position autocorrelation within saccades. Each image shows the effect of reward on mean correlation coefficient
between the eye-position at one (interpolated) time-point within a saccade with all other time-points in that same saccade. As noise accumulates
during the movements, the correlations increase over the time-points, while reductions in correlation can suggest negative feedback during
movements. The top row shows the effect of contingent rewards (Performance – Random) on the (Fisher transformed) autocorrelation coefficients, and
the bottom row shows the effect of guaranteed rewards (10 p – 0 p). Green areas mean that motivation increased correlation, while purple areas reflect
a decrease, and clusters significantly different from zero are outlined in black (cluster permutation testing, p<0.05). When examining the dopaminergic
effects (a and e: PD ON – OFF), a significant cluster was found, such that patients differed in their correlations early in the saccade when rewards were
guaranteed (e). This was due to guaranteed rewards increasing early correlation only for PD OFF (g). The time of this increase matches the time of
increased acceleration shown in Figure 3d. There was also a small cluster of significant difference between PD ON and OFF for contingent rewards (a),
but there were no clusters within ON (b) or OFF (c) separately. HC had no clusters of significant differences (d and h). Source data are available in
Figure 4—source data 1. Figure 4—source data 2. Individual data for autocorrelation. Figure 4—figure supplement 1. Motivational effects on
saccade time-time covariance within saccades.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Source individual data for autocorrelation coefficients for PD ON, OFF and HC.
Source data 2. Individual participants’ autocorrelation matrices.
Figure supplement 1. Motivational effects on time-time covariance within saccades.
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PD OFF had more microsaccades (<1˚) during the 1400ms fixation period than PD ON (F (1, 201)
= 5.0451, p = .0258, h2
p
= . 0245), but there were no other effects or interactions (p >.05, Supple-
mentary File 3A for statistics). Conversely, ocular drift speed was higher in PD ON than OFF (F (1,
216) = 5.4327, p = .0207, h2
p
= .0245), but there were no other significant effects or interactions (p
>.05, see Supplementary File 3B). Importantly, the lack of interactions means that while patients may
have differed in their fixation activity, this was unaffected by motivation conditions, and thus a differ-
ent pattern to the main effects shown above.
To quantify ocular tremor, we performed Fourier transforms on the eye position in the early (200–
700 ms) and late (700–1200 ms) fixation periods, and compared these between conditions with clus-
ter-wise permutation tests to look for clusters of frequencies where patients differed. We found no
significant clusters (p>0.05).
Discussion
In this study, we tested two competing theories of dopaminergic motivation – that dopamine
improves instrumental, contingent motivation, and that dopamine improves guaranteed reward
motivation via reward expectation. Patients with PD made more vigorous responses, measured by
peak saccade velocity residuals (Figure 2a), when rewards were either contingent on performance
or guaranteed, but these two effects were differentially affected by dopaminergic medication. When
ON medication, PD patients were motivated by rewards contingent on performance, but not by
guaranteed rewards. In contrast, when patients were OFF their dopaminergic medication, the
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Figure 5. No correlations between contingent and guaranteed rewards. Scatter plots of the effect of contingent and guaranteed rewards (i.e.
contingent effect = Performance minus Random trials, guaranteed effect = guaranteed 10 p minus guaranteed 0 p trials) on peak velocity residuals,
within each group (top row: PD ON, PD OFF, HC), and between medication conditions (bottom row). Dots show the mean values. No Spearman’s
correlations were significant (ON: r =  0.1549, p=0.4503; OFF: r = 0.3730, p=0.0614; HC: r =  0.2153, p=0.2609; Contingent ON vs OFF: r =  0.3429,
p=0.0869; Guaranteed ON vs OFF: r = 0.1432, p=0.4834; ON-OFF Contingent vs Guaranteed: r =  0.2438, p=0.2291).
The online version of this article includes the following source data for figure 5:
Source data 1. Source individual data for velocity residual correlations for PD ON, OFF and HC.
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opposite pattern was observed; they were motivated by guaranteed rewards, but not by rewards
contingent on performance. In this study, older healthy controls were not significantly invigorated by
either guaranteed or contingent rewards, although they showed a numerically similar pattern to PD
ON. Guaranteed rewards led to PD OFF having earlier increases in velocity and acceleration
(Figure 3c & d), which was not seen in PD ON or when rewards were contingent, and this was
accompanied by increased autocorrelation of eye position (Figure 4), suggesting increased motor
noise early in the saccade. The two motivational effects were uncorrelated across people and
between medication states (Figure 5) indicating that dopamine does not promote one type of moti-
vation over another in a competitive fashion, and were not associated with changes in pupil dilata-
tion (Figure 6). Rather, reward expectation and contingency provide distinct motivational drives
(Figure 7), which can be dissociated by dopaminergic medication.
The results suggest that dopamine is necessary for contingent motivation. Contingent motivation
requires the use of stimulus-action-outcome associations for goal-directed behaviour (Daw and
Dayan, 2014; Dickinson, 1985), while reward expectation can occur via stimulus-outcome associa-
tions (Niv et al., 2007) that do not require understanding the causal role of action. Our results align
with rodent work demonstrating that dorsomedial striatum dopaminergic lesions impair action-out-
come associations, such that animals continue to respond to previously rewarding cues even when
action-contingency is removed (Lex and Hauber, 2010b). At a more general level, our result is also
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Figure 6. No effects of motivation on pupil dilatation. The effects of contingent (top) and guaranteed rewards (bottom) on pupil dilatation in the
different conditions up to 1400 ms after the reward cue. Pupil dilatation is baselined to the time of cue onset. There were no significant clusters of
difference between any groups (cluster-wise permutation testing: p>0.05), nor did a window-of-interest (1000–1400 ms) ANOVA find any significant
effects (Supplementary file 2A-C). Shading shows SEM. Source data are available in Figure 6—source data 1. Figure 6—figure supplement 1. No
correlation of pupil dilatation and motivational effects on velocity. Figure 6—figure supplement 2. Individual data for pupil dilatation.
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. Source individual data for pupil dilatation for PD ON, OFF and HC.
Figure supplement 1. No correlation of pupil dilatation and motivational effects on velocity.
Figure supplement 2. Individual data for pupil dilatation.
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consistent with dopamine being necessary for behaviours involving a causal state-action-state model
(Sharpe et al., 2017), but not simple value-guided actions (Sharp et al., 2016).
Our finding reveals that dopaminergic medication attenuates the cue-driven reward expectation
effect on vigour can be contrasted with previous work suggesting that tonic dopamine couples vig-
our to average reward rate (Beierholm et al., 2013; Niv et al., 2007). Our adaptive reward schedule
held the average reward rate constant over time, while manipulating the average reward rate within
each condition, such that the guaranteed 10 p and 0 p trials had different expected rewards. Dopa-
mine might reduce these expectation effects through a different mechanism; the guaranteed cues
elicit Pavlovian signals that track expected rewards across states and cues rather than time. Our
result implicates dopamine in this signalling, but the direction of effect contrasts with naı¨ve predic-
tions. Dopamine is necessary for Pavlovian-to-Instrumental transfer (Hall et al., 2001; Kelley and
Delfs, 1991; Wyvell and Berridge, 2000) via the nucleus accumbens. In contrast, we show that
reward expectation influences vigour when dopaminergic tone is low, yet does not when dopaminer-
gic tone is high. This aligns with the finding that slow, tonic dopaminergic activity is not related to
Pavlovian-to-Instrumental transfer (Wassum et al., 2013). A possible explanation is that being ON
dopamine led to a saturation in tonic dopamine leaving little room for phasic cue-related reward
expectation signals. But if this were the case, one might expect generally higher velocities when ON,
compared to PD OFF, which was not seen. Because our contingent and random conditions were
matched for average reward rate, and thus opportunity cost, invigoration by contingent reward indi-
cates a truly instrumental effect.
An alternative explanation for the discrepancy with previous research showing dopamine encodes
reward rate, is that the previous studies did not fully decouple contingent and non-contingent moti-
vation. In many studies, expected rewards were only given for successful performance
(Beierholm et al., 2013; Niv et al., 2007), meaning the rewards were still contingent on perfor-
mance. However, when separated, contingent motivation has larger effects on vigour than reward
expectation (Manohar et al., 2017), and so it is possible that some previously reported effects of
average reward rate on vigour were due to the greater contingency, separate from or in addition to,
reward expectation. Indeed, vigour may be reduced by dopamine in PD, though reward sensitivity is
increased (Muhammed et al., 2016). An additional challenge to the tonic dopamine theory of
reward expectation comes from the finding that fast phasic dopaminergic responses in the nucleus
accumbens encode average reward rate, but slow tonic responses do not (Mohebi et al., 2019).
That study suggests that reward expectation signals are independent of ventral tegmental area
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Figure 7. Proposed model for dopaminergic dissociation of reward expectation and contingent motivation. We propose that dopamine (in PD
patients) increases contingent motivation by acting on the caudate nucleus, which disinhibits the superior colliculus (via the basal ganglia output nuclei)
and affects the firing activity within the saccade, influencing vigour. Separately, high tonic dopamine impairs reward expectation motivation via the
nucleus accumbens and ventral pallidum, which also disinhibit the basal ganglia output nuclei to affect superior colliculus firing activity and thus vigour
within the saccade. Possible mechanisms for this dissociative dopamine influence include separate dopaminergic regions innervating the two pathways,
‘global’ vs ‘local’ signalling, or different expression of D1-like and D2-like receptors (see text for details).
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dopaminergic neuron firing, and may instead be due to ‘local’ control over nucleus accumbens core
dopamine release. As dopamine is depleted in PD via dopamine-neuron death in the substantia
nigra and ventral tegmental area, local dopamine release in other areas may be relatively preserved,
and thus still able to influence vigour when PD patients are without dopamine.
The effect of reward-expectation on peak velocity was accompanied by greater velocity, accelera-
tion, and autocorrelation early in the saccade for PD OFF than ON. Greater autocorrelation at this
point is expected, as greater velocity increases noise (Harris and Wolpert, 2006; Fitts, 1954). How-
ever, this noise increase did not persist until the end of the saccade, as there was no increase in
autocorrelation at the end of the saccade (Figure 4) and no greater endpoint variability (Figure 2e)
– indeed, guaranteed rewards actually decreased endpoint variability, although this was not affected
by dopamine. This offers some indirect evidence that the increased noise in this condition was atten-
uated via negative feedback (c.f. Manohar et al., 2019).
PD patients had slower saccadic RTs, and slower, smaller and more variable saccades compared
to age-matched controls. The pattern of invigoration also differed from controls, who did not show
significant effects of either contingent motivation or reward-expectation on speed. Instead, controls
had lower motor variability when rewards were guaranteed, but no other significant motivation
effects. This leads to a pattern where PD ON show contingent motivation, PD OFF show reward-
expectation effects, and HC show neither. As these effects themselves are not statistically different
between groups, we are limited in the conclusions that we can draw about them. Numerically, con-
trols show a similar pattern to PD ON (Figure 2a), with faster velocity residuals for contingent
rewards, which could suggest that dopaminergic medication is restoring healthy function, but care
must be taken with this interpretation. The lack of either type of motivation in the older HC is sur-
prising given that in healthy young adults, both contingent and guaranteed rewards increase sac-
cade velocity (Manohar et al., 2017). This could suggest ageing decreases both contingent-
motivation and reward-expectation, although a study directly comparing ages would be needed to
conclude this.
The motivational effects reported here were not related to any pupillary responses, unlike our
previous findings in young people, which may be due to both ageing and PD decreasing the influ-
ence of rewards on pupil size (Manohar and Husain, 2015; Muhammed et al., 2016). Additionally,
while the two distinct motivational effects on velocity were uncorrelated within PD patients, it is pos-
sible that subgroups of patients showed different effects. For example, whether patients were on D2
agonists (Bryce and Floresco, 2019) or had tremor-dominant disease (Wojtala et al., 2019) might
be relevant. However, this study was not powered to detect such differences as only six patients
were taking agonists in addition to levodopa.
Considering the neuroanatomical differences between contingent motivation and reward expec-
tation may help to explain our results. The nucleus accumbens and ventral pallidum modulate their
activity by reward expectation (Mohebi et al., 2019; Tachibana and Hikosaka, 2012), while the cau-
date nucleus is active when rewards are contingent on behaviour (Lex and Hauber, 2010a;
Tricomi et al., 2004). Both the caudate and accumbens/pallidum project to the output nuclei of the
basal ganglia, allowing saccade initiation via the superior colliculus, which controls not only the direc-
tion of saccades, but also their instantaneous velocity during the movement (Smalianchuk et al.,
2018). We propose contingent motivation and reward expectation both lead to motivational signals
affecting the superior colliculus’ activity controlling the velocity and acceleration of saccades, and
these are differentially affected by dopamine (Figure 7), although we remain agnostic as to the
mechanism for this difference. Possibilities include the two systems receiving input from separate
regions of the dopaminergic system which are differentially depleted in PD (e.g. dopamine overdose
hypothesis [Cools, 2006]), differences in ‘global’ and ‘local’ dopamine signals (Mohebi et al., 2019),
or differences in D1-like and D2-like receptor expression within these systems (Surmeier et al.,
2007; Yetnikoff et al., 2014). Further studies should address this question of the underlying
mechanism.
We have shown that in PD, dopaminergic medication boosts motivation by contingent rewards,
but reduces motivation by expected reward. Nonspecific invigoration by reward may thus be gener-
ated by a different neural system than goal-directed motivation. This suggests that dopaminergic
medication may be a potential treatment for impairments in contingent motivation, but not for defi-
cits related to reward expectation.
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Materials and methods
Participants
Thirty PD patients were recruited from volunteer databases in the University of Oxford. They were
all taking levodopa medication, and some were also taking monoamine oxidase inhibitors and/or
dopamine agonists (Table 3). They were randomly assigned to be tested ON or OFF medication
first, and withdrawn from standard release medication for 16+ hours and controlled-release medica-
tion for 24+ hours. Two patients did not complete both sessions, and two did not have enough trials
that passed all the criteria (see Analysis section) so were excluded, leaving 26 patients. Thirty healthy
controls (HC) were recruited from volunteer databases also, and tested once, and one HC was
excluded for insufficient trials passing the criteria. We recruited 30 participants in each group as this
was the sample size used in previous experiments with this task and yielded robust effects
(Manohar et al., 2017). Sensitivity power calculations showed this would detect effect sizes above
0.46 (Faul et al., 2009) (a = 0.05, power = 0.8, sample size = 30), although as we only included 26
PD in the analysis, this effect size rose to 0.5.
All participants gave written informed consent, and ethical approval was granted by the South
Central Oxford A REC (18/SC/0448).
Procedure
The task was run in Matlab (www.mathworks.com, version 7) using the Psychophysics toolbox
(Kleiner et al., 2007), on a Windows XP computer with a CRT monitor (1024  768 pixels, 40  30
cm, 100 Hz refresh rate) at 70 cm viewing distance. Eye movements and pupil size were recorded
with Eyelink1000 at 1000 Hz.
On each trial of the task a fixation dot (0.3˚ radius) was presented at the centre of the screen, with
two empty circles (1.1˚ radius) shown 9.3˚ to the left and right of the fixation dot. After 500 ms of fixa-
tion, a cue was given by a voice over the speaker, indicating the type of trial the participant was in:
. ‘Performance’ indicated that fast response times would win 10 p, while slow response times
would win 0 p
. ‘Random’ indicated a 50% probability of 10 p or 0 p, regardless of response time
. ‘Ten pence’ indicated a guaranteed 10 p, regardless of response time
. ‘Zero pence’ indicated guaranteed 0 p, regardless of response time
A delay of 1400, 1500 or 1600 ms was given (with equal probability), after which one of the two
circles turned white (50% probability of left or right) and participants had to saccade to this circle to
complete the trial and receive the outcome.
Participants could only affect the outcome in the Performance condition (by moving faster); all
others were independent of their speed. In the Performance condition, rewards were based upon
response time (i.e. total time between the target appearing and gaze arriving at the target), which is
only minimally influenced by saccade velocity. Participants were rewarded when response time was
quicker than their recent median response time for the last 20 Performance trials, which thus yielded a
50% reward rate overall. The Random condition acts as a control to these trials, with a random 50% of
trials rewarded, and thus equal expected value but with no performance-contingency. Rewards in the
guaranteed conditions also had zero contingency on performance, but yielded different expected
rewards (10 p vs 0 p), thus comparing them indexes the pure effect of expecting reward.
When rewards are contingent, people get feedback about how they performed. This itself is
known to increase motivation, independent of reward – a phenomenon termed intrinsic motivation.
To control for this, we ensured participants always received feedback on their speed (fast/slow, using
median split over 20 previous trials in that condition – i.e. the same criteria as for contingent
rewards), regardless of reward. This should equate the level of intrinsic motivation across conditions,
providing that the feedback is as noticeable as the reward. In order to ensure the speed feedback
and reward were matched in physical salience, the feedback modalities were counterbalanced. Two
blocks gave auditory feedback for speed and visual feedback for reward, and vice versa for the other
two blocks, with order randomised across participants. This counterbalancing accords with our previ-
ous study (Manohar et al., 2017) which found no modality effects, suggesting participants were
attending to audio and visual feedback equally. We also found no effects of modality on any of the
measures of interest (p>0.05), so collapsed across the two modalities for all the analyses.
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There were 12 types of each trial in a block, in a random order, and participants completed four
blocks.
Analysis
The Performance and 10 p conditions are high motivation conditions. The difference between Per-
formance and Random conditions gives the effect of contingent motivation, while the difference
between 10 p and 0 p conditions gives the effect of reward expectation.
As in previous studies (Manohar et al., 2017), our primary measure of interest was saccadic vig-
our. We measured peak saccade velocity on each trial. We took the first saccade after target onset
which was greater than 1˚ in amplitude, and used a sliding window of 4 ms width to calculate veloc-
ity, excluding segments faster than 3000˚s 1 or where eye tracking was lost. Saccades with peak
velocities outside 80–2500˚s 1 were excluded, as were trials where participants reached the target
before 180 ms or after 580 ms. Two PD patients and one HC had fewer than 10 trials that passed
these criteria for one condition, so were excluded from the analysis.
To remove the main sequence effect of amplitude on velocity (Bahill et al., 1975; Harris and
Wolpert, 2006), we regressed velocity against amplitude and took the peak velocity residuals as our
measure of interest. This measures the difference between the velocity predicted by the main
sequence, and the velocity actually recorded, with positive (negative) values meaning faster (slower)
velocity. This was done for each participant’s separate session. This approach has been used before,
by us and others (Blundell et al., 2018; Manohar et al., 2017; Muhammed et al., 2020;
Muhammed et al., 2016; Van Opstal et al., 1990), and it is similar to simply including amplitude as
a covariate when analysing raw peak velocity, but it does not reduce the degrees of freedom and
yields simpler to interpret results. Moreover since motivation increases amplitude (Manohar et al.,
2019), including amplitude as a covariate would mean that amplitude would compete with motiva-
tion to explain variance in velocity, potentially resulting in overestimation of motivation effects. Our
findings did not qualitatively change when we used the covariate approach instead.
We also measured amplitude, saccadic reaction time (RT), and endpoint variability of these sac-
cades. Saccadic RT is the time between the target onset and the start of the saccade.
To analyse velocity and acceleration traces, and autocorrelation and covariance of the eye move-
ments we linearly interpolated 50 points along each saccade to move them into the same units.
Instantaneous velocity was smoothed across three time-points, while acceleration was smoothed
across 5. We also calculated velocity and acceleration traces on the raw (non-interpolated) traces
and then interpolated them afterwards, which gave very similar results.
Pupil dilatation was measured in arbitrary units (a.u.) relative to the baseline pupil size at the cue
onset. Blinks under 500 ms were linearly interpolated, steps in pupil size above 2.5 a.u./ms were
removed, and data were averaged in 20 ms bins for plotting.
We used rmanova from the matlib toolbox (https://github.com/sgmanohar/
matlib; Manohar, 2020) to perform analyses – this uses fitglme to perform the repeated-measures
test and anova to perform hypothesis tests on the GLME. We used three-way repeated-measures
ANOVA to compare effects of motivation, contingency and dopaminergic medication in PD patients,
and followed this up with two-way ANOVA when a three-way interaction was found. These analyses
were also performed using a full linear mixed effects model including each trial, which produced
qualitatively identical results. To compare each PD condition against HC we used mixed ANOVA.
We also used cluster-wise permutation tests for the time-course data (velocity, acceleration, pupil
dilatation, autocorrelation and covariance), to control the family-wise error rate at. 05.
Data and code availability
Analyses were performed in Matlab using custom scripts, which are available on GitHub (https://doi.
org/10.5281/zenodo.4032711). Anonymous data are available on OSF (https://osf.io/2k6x3), as is
the experiment file (osf.io/y9xhp) https://doi.org/10.5281/zenodo.4032711.
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